P414 ASSESSMENT OF THE CHANGE IN ESTIMATED GLOMERULAR FILTRATION RATES IN TELBIVUDINE- OR LAMIVUDINE-BASED TRERAPY IN PATIENTS WITH CHRONIC HEPATITIS B
J. Sun,J. Cheng,X. Chen,Q. Xie,D. Tan,H. Wang,S. Chen,Y. Yu,H. Tang,J. Niu,J. Sheng,Y. Sun,Q. Ning,M. Wan,X. Bai,G. Shi,H. Ren,M. Xu,X. Dou,J. Shi,J. Jiang,H. Long,M. Wang,H. Zhang,Z. Gao,C. Chen,H. Ma,J. Jia,J. Hou
DOI: https://doi.org/10.1016/s0168-8278(14)60576-6
IF: 25.7
2014-01-01
Journal of Hepatology
Abstract:P414 ASSESSMENT OF THE CHANGE IN ESTIMATED GLOMERULAR FILTRATION RATES IN TELBIVUDINEOR LAMIVUDINE-BASED TRERAPY IN PATIENTS WITH CHRONIC HEPATITIS B J. Sun, J. Cheng, X. Chen, Q. Xie, D. Tan, H. Wang, S. Chen, Y. Yu, H. Tang, J. Niu, J. Sheng, Y. Sun, Q. Ning, M. Wan, X. Bai, G. Shi, H. Ren, M. Xu, X. Dou, J. Shi, J. Jiang, X. Chen, H. Long, M. Wang, H. Zhang, Z. Gao, C. Chen, J. Jiang, H. Ma, J. Jia, J. Hou. Hepatology Unit, Nanfang Hospital, Guangzhou, Beijing Ditan Hospital, Beijing Youan Hospital, Beijing, Ruijin Hospital, Shanghai, Xiangya Hospital, Changsha, Peking University People’s Hospital, Beijing, Ji’nan Infectious Diseases Hospital, Ji’nan, First Hospital of Peking University, Beijing, Huaxi Hospital, Chengdu, No. 1 Hospital Affiliated to Jilin University, Changchun, Zhejiang University 1st Affiliated Hospital, Hangzhou, Tangdu Hospital, Xi’an, Tongji Hospital, Wuhan, Changhai Hospital, Shanghai Huashan Hospital, Shanghai, Chongqing Medical University 2nd Affiliated Hospital, Chongqing, 8th People’s Hospital, Guangzhou, Shengjing Hospital, Shenyang, 6th People’s Hospital, Hangzhou, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangdong General Hospital, Guangzhou, The First People Hospital of Foshan, Foshan, 81st PLA Hospital, Guangzhou, 302nd PLA Hospital, Beijing, Sun Yat-Sen University 3rd Affiliated Hospital, Guangzhou, 85th PLA Hospital, Shanghai, The First Affiliated Hospital of Fujian Medical University, Fuzhou, Beijing Friendship Hospital, Beijing, China E-mail: doctorsunjian@qq.com Background and Aims: Recent pooled analyses of multiple studies of telbivudine in patients with chronic hepatitis B (CHB) demonstrated that telbivudine therapy was associated with a consistent increase of estimated Glomerular Filtration Rates (eGFR). The aim of this study was to validate the effect on eGFR of telbivudineor lamivudine-based therapy in two multi-center, randomized controlled studies in Chinese CHB patients. Methods: 606 and 366 compensated HBeAg positive CHB patients were enrolled in the EFFORT (NCT00962533) and EXPLORE (NCT01088009) studies with similar study design based on ROADMAP concept, receiving telbivudine-based and lamivudinebased therapies for up to 104 weeks, respectively. Adefovir was added to patients per protocol at baseline or week 28, or at virological breakthrough. eGFR was assessed with aMDRD equation.